Meditrial Europe

Meditrial is a specialized clinical research organization (CRO) and regulatory consultancy that focuses on the medical device and digital health sectors. The company provides comprehensive support for clinical trials, including study design, monitoring, and data management, with a particular emphasis on navigating European MDR and FDA regulatory pathways. Meditrial is well-known for its proprietary CatchTrial platform, which offers integrated electronic data capture (EDC) and clinical trial management system (CTMS) capabilities. Headquartered in Switzerland with offices across Europe and the United States, the firm serves as a strategic partner for medical technology companies seeking to bring innovative devices to market. Following its acquisition by NAMSA in 2022, Meditrial has integrated its regional expertise into a broader global service offering.